Baotou Dongbao Bio-TechLtd Valuation

Is 300239 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 300239 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 300239 (CN¥5.37) is trading above our estimate of fair value (CN¥0.02)

Significantly Below Fair Value: 300239 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300239?

Key metric: As 300239 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 300239. This is calculated by dividing 300239's market cap by their current earnings.
What is 300239's PE Ratio?
PE Ratio	35.1x
Earnings	CN¥90.90m
Market Cap	CN¥3.19b

300239 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.5x
Enterprise Value/EBITDA	16.9x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 300239's PE Ratio compare to its peers?

The above table shows the PE ratio for 300239 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	37.3x
688089 Cabio Biotech (Wuhan)	30.4x	22.4%	CN¥3.5b
002054 Dymatic ChemicalsInc	63.4x	n/a	CN¥3.0b
605488 Zhejiang Fulai New MaterialLtd	33.8x	n/a	CN¥2.8b
301373 GuangZhou LingWe Technology	21.5x	n/a	CN¥2.8b
300239 Baotou Dongbao Bio-TechLtd	35.1x	n/a	CN¥3.2b

Price-To-Earnings vs Peers: 300239 is good value based on its Price-To-Earnings Ratio (35.1x) compared to the peer average (37.3x).

Price to Earnings Ratio vs Industry

How does 300239's PE Ratio compare vs other companies in the CN Chemicals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 300239 is good value based on its Price-To-Earnings Ratio (35.1x) compared to the CN Chemicals industry average (35.2x).

Price to Earnings Ratio vs Fair Ratio

What is 300239's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300239 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	35.1x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 300239's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Yunnan Yuntianhua

CN¥40.3b

Engages in the phosphate ore mining, chemical fertilizers, engineering materials, agriculture, and trade and logistics businesses in China.

600096

CN¥22.08

-1.3%

37.5%

Chifeng Jilong Gold MiningLtd

CN¥29.1b

Operates as a gold and non-ferrous metal mining company.

600988

CN¥17.66

2.7%

31.4%

MeiHua Holdings GroupLtd

CN¥30.1b

A synthetic biology company, provides amino acid nutrition and health solutions in China and internationally.

600873

CN¥10.55

4.6%

12.2%